Imaging utilization increaseswhere radiologists wane
Diagnostic imaging utilization rates don’t just swing wildly across the 10 Medicare regions.
Diagnostic imaging utilization rates don’t just swing wildly across the 10 Medicare regions. According to Thomas Jefferson University researchers, the areas with the highest utilization rates also have the lowest percentage of radiologists.
TJU radiology chair Dr. Vijay Rao and colleagues looked at trends in noninvasive imaging services over a five-year period ending in 2006 using the Medicare Part B feefor- service database. In 2006, utilization rates per 1000 beneficiaries ranged from a high of 4532 in the Atlanta region to a low of 2901 in the Seattle region. Radiologists’ share of the imaging services provided ranged from 69% in the Boston region to a low of 58% in the Atlanta region. Plotting radiologist share against the overall utilization rates showed that the higher the utilization rate, the lower the percentage of radiologists providing the services. Rao released findings at the 2008 RSNA meeting.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
